Mark J. Alles - Director at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SYRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark J. Alles since 7/7/2023

Holdings reported by Mark J. Alles for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 3,666 $16.2 K $4.42 Sep 16, 2023 Direct
Restricted Stock Units 5,334 $11.8 K $2.22 Sep 16, 2023 Direct Common Stock

Transactions reported by Mark J. Alles for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership